Published in Women's Health Weekly, December 30th, 2004
"We're pleased to be in a position to include the full data set from the PaTH study without unreasonable delay in the timing of our NDA submission," said Hunter Jackson, PhD, chairman, president, and CEO at NPS.
Jackson continued, "Data from the second year of the study include unique insights into the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.